Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Pattern of Use for Gadolinium-Based Contrast Agents (GBCAs) in Patients Undergoing Contrast-Enhanced Magnetic Resonance (CE-MR) Examination - A Prospective, Multicenter, Observational Study

NCT03455283 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT03455283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03455283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Pattern of Use for Gadolinium-Based Contrast Agents (GBCAs) in Patients Undergoing Contrast-Enhanced Magnetic Resonance (CE-MR) Examination - A Prospective, Multicenter, Observational Study
Lead sponsor
GE Healthcare
Phase
Observational
Overall status
Completed
Start date
December 17, 2018
Completion date
November 11, 2019
Enrollment
2,118 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance imaging (mri)